Risk factors for Parkinson’s disease depression
Main Authors: | Jamir Pitton Rissardo, Ana Letícia Fornari Caprara, Ícaro Durante |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Annals of Movement Disorders |
Online Access: | http://www.aomd.in/article.asp?issn=2590-3446;year=2022;volume=5;issue=2;spage=134;epage=136;aulast=Rissardo |
Similar Items
-
Pimavanserin and Parkinson’s Disease Psychosis: A Narrative Review
by: Jamir Pitton Rissardo, et al.
Published: (2022-09-01) -
Neuroimaging Techniques in Differentiating Parkinson’s Disease from Drug-Induced Parkinsonism: A Comprehensive Review
by: Jamir Pitton Rissardo, et al.
Published: (2023-11-01) -
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
by: Jamir Pitton Rissardo, et al.
Published: (2023-10-01) -
The effect of “liquid gold” levodopa–carbidopa ascorbic acid solution in patients with Parkinson’s disease
by: Jamir Pitton Rissardo, et al.
Published: (2023-01-01) -
Neurocysticercosis and movement disorders: A literature review
by: Jamir Pitton Rissardo, et al.
Published: (2020-01-01)